Dr Reddys Laboratories (RDY) Equity Ratio (2012 - 2026)

Dr Reddys Laboratories' Equity Ratio history runs 12 years deep, the most recent figure standing at 0.66 for Q1 2026.

• In Q1 2026, Equity Ratio fell 2.89% year-over-year to 0.66; the TTM figure through Mar 2026 stood at 0.66 (down 2.89% YoY), while the FY2026 annual figure was 0.61, down 8.52% from the prior year.
• Equity Ratio was 0.66 for Q1 2026 at Dr Reddys Laboratories, down from 0.68 in the prior quarter.
• In the past five years, Equity Ratio ranged from a high of 0.72 in Q1 2024 to a low of 0.65 in Q1 2022.
• Historically, Equity Ratio has averaged 0.69 across 5 years, with a median of 0.68 in 2025.
• The sharpest annual moves came in 2023 and 2025: Equity Ratio climbed 10.3% in 2023, then retreated 6.59% in 2025.
• A 5-year view of Equity Ratio shows it stood at 0.65 in 2022, then gained by 10.3% to 0.72 in 2023, then advanced by 0.87% to 0.72 in 2024, then fell by 6.59% to 0.68 in 2025, then retreated by 2.89% to 0.66 in 2026.
• The last three Equity Ratio figures came in at 0.66 (Q1 2026), 0.68 (Q1 2025), and 0.72 (Q1 2024), per Business Quant data.